Avaleht › Lümfödeem › New York
Lümfödeem kliinilised uuringud osariigis New York
5 uuringut haiguse Lümfödeem jaoks otsivad osalejaid osariigis New York.
Linnad osariigis New York
Ametlik uuringutekst (inglise keeles)
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre
VärbamineVaatlusuuring
Vanused 18–80 · Kõik sood · Uuendatud 24. sept 2026 · NCT03248310A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
- Erie County Medical Center, Buffalo
- Icahn School of Medicine at Mount Sinai, New York
VärbamineVaatlusuuring
Vanused 22 ja vanemad · Kõik sood · Uuendatud 11. sept 2026 · NCT06725030Lymphedema Surveillance Study
- Memorial Sloan Kettering Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ja veel 1
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Naised · Uuendatud 7. mai 2026 · NCT02743858Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
- Glenn Jacobowitz, New York
Värbamine
Vanused 18–100 · Kõik sood · Uuendatud 4. mai 2026 · NCT06418282A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ja veel 1
VärbamineFaas 3
Vanused 18–75 · Naised · Uuendatud 10. nov 2025 · NCT06144164Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.